CCS
ZBH icon

Crosspoint Capital Strategies’s Zimmer Biomet ZBH Stock Holding History

Crosspoint Capital Strategies’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-12
Closed -$1K – 848
2015
Q4 		$1K Buy
+12
New +$1.17K ﹤0.01% 968
2015
Q1 		– Sell
-28
Closed -$3K – 759
2014
Q4 		$3K Hold
28
– – ﹤0.01% 667
2014
Q3 		$3K Hold
28
– – ﹤0.01% 450
2014
Q2 		$3K Hold
28
– – ﹤0.01% 473
2014
Q1 		$3K Hold
28
– – ﹤0.01% 627
2013
Q4 		$3K Buy
+28
New +$2.42K ﹤0.01% 533

Other funds holding ZBH

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Crosspoint Capital Strategies's ZBH Position: Q1 2016 in Review

Crosspoint Capital Strategies sold out of Zimmer Biomet (ZBH) in Q1 2016, closing a stake of 12 shares — an estimated $1K sold.

Crosspoint Capital Strategies first reported a position in ZBH in Q4 2013 and held it in 6 quarters. The position peaked at $3K in Q4 2014. 746 funds tracked by Wall St. Rank hold ZBH as of Q1 2016.

  • Crosspoint Capital Strategies reported no remaining Zimmer Biomet position as of Q1 2016 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 12 Zimmer Biomet shares in Q1 2016, an estimated $1K.
  • Crosspoint Capital Strategies first reported a position in Zimmer Biomet in Q4 2013 and held it in 6 quarters.
  • Crosspoint Capital Strategies's Zimmer Biomet position peaked at $3K in Q4 2014.
  • 746 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2016.

Based on Crosspoint Capital Strategies's 13F filing for Q1 2016, filed 16 May 2016.